NMP22

From Wikipedia, the free encyclopedia

NMP22 is a tumor marker for bladder cancer. NMP22 is the abbreviated form of Nuclear Matrix Protein No.22 [1][2][3]

References

  1. ↑ Kumar A, Kumar R, Gupta NP (March 2006). "Comparison of NMP22 BladderChek test and urine cytology for the detection of recurrent bladder cancer". Jpn. J. Clin. Oncol. 36 (3): 172–5. doi:10.1093/jjco/hyi244. PMID 16520358. 
  2. ↑ Moonen PM, Kiemeney LA, Witjes JA (December 2005). "Urinary NMP22 BladderChek test in the diagnosis of superficial bladder cancer". Eur. Urol. 48 (6): 951–6; discussion 956. doi:10.1016/j.eururo.2005.09.002. PMID 16257108. 
  3. ↑ Bassi P, De Marco V, De Lisa A, et al. (2005). "Non-invasive diagnostic tests for bladder cancer: a review of the literature". Urol. Int. 75 (3): 193–200. doi:10.1159/000087792. PMID 16215303. 
Blood
Lymphosarcoma
Endocrine
Neuroendocrine tumors
Nervous system
  • PCNA
Cardiovascular/
respiratory
Digestive
Reproductive/
urinary/
breast
General histology
Musculoskeletal

M: NEO

tsoc, mrkr

tumr, epon, para

drug (L1i/1e/V03)

This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.